
- KCBS In Depth, April 28, 2012, featuring an interview with Dr. Nathan Wolfe
In April 2012, the possibility of another worldwide pandemic was a subject of growing concern among scientists, public health officials and researchers. The 2009 H1N1 Swine Flu pandemic was still relatively fresh in the public memory, while Bird Flu (H5N1) continued to raise alarms because of its unusually high mortality rate among those infected. But there was another, perhaps more unsettling question emerging from the scientific community: What if the next virus combined the ability to spread rapidly with the ability to kill on a massive scale?
That was among the subjects explored on April 28, 2012, during KCBS In Depth, a San Francisco radio program featuring an interview with Dr. Nathan Wolfe, a virologist associated with Stanford University and founder of the Global Viral Forecasting Initiative. Wolfe had spent years studying viruses at their point of origin, particularly in areas where human populations came into close contact with wild animals. His concern was not simply treating an outbreak after it appeared, but identifying potentially dangerous viruses before they had an opportunity to spread.
One of the important distinctions Wolfe discussed was the relationship between a virus’s transmissibility and its lethality. The two characteristics do not necessarily go hand in hand. The H1N1 Swine Flu virus, which spread internationally in 2009, was highly contagious but, for most people, was not especially deadly. H5N1, by contrast, had demonstrated a frighteningly high fatality rate among confirmed human cases, but had not developed the ability to spread efficiently from person to person.
The danger was the possibility of these characteristics combining. Influenza viruses can exchange genetic material when different strains infect the same host. A new strain with the transmissibility of H1N1 and the lethality associated with H5N1 represented a particularly troubling possibility. It was not inevitable, but it was precisely the sort of development that made early detection so important.
There was also a less familiar side to the discussion: viruses are not necessarily the enemy of human health. Although certain viruses cause devastating diseases, others have been useful in medical research and prevention. Vaccines have long relied on weakened or inactivated viruses to teach the immune system to recognize and fight infection. Scientists have also learned to use modified viruses as delivery systems in gene therapy and other medical applications. Understanding viruses, therefore, is not simply about learning how to destroy them. It is about understanding their extraordinary biological capabilities and finding ways to use that knowledge to protect human life.
Wolfe’s larger argument concerned preparedness. He believed the world was spending too much time reacting to epidemics after they became visible and not nearly enough time identifying them at their source. Increased international travel, expanding populations and the continuing interaction between humans and animals meant that an infection once confined to a remote community could become an international emergency in a matter of weeks.
Fourteen years later, we have an answer to at least part of that warning. COVID-19 demonstrated just how quickly a previously unknown virus could travel around the world, overwhelm hospitals, disrupt economies and expose weaknesses in public health systems. The experience also demonstrated that scientific cooperation could produce extraordinary results. Vaccines were developed and distributed in record time, genomic sequencing helped track viral changes, and international research networks shared information on an unprecedented scale.
But COVID-19 also revealed something considerably less encouraging: the United States and much of the world were not as prepared as they believed themselves to be. Shortages of protective equipment, inadequate testing capacity, overwhelmed hospitals, inconsistent public information and political disagreements over basic public health measures exposed weaknesses that had accumulated over decades. The pandemic was not simply a medical emergency. It became a test of government, public confidence, scientific communication and international cooperation.
One might reasonably have expected that experience to produce a sustained commitment to strengthening public health infrastructure. Some progress was made. In May 2025, the World Health Organization adopted its first Pandemic Agreement, intended to improve international cooperation and create a more equitable system for sharing medical resources, vaccines and treatments during future emergencies. But even that effort remains unfinished. As of November 2026, negotiations over its critical Pathogen Access and Benefit-Sharing provisions are continuing, with completion targeted for May 2027.
And what of the United States?
Here, the picture is considerably more troubling. The Trump administration’s restructuring of the Department of Health and Human Services, carried out under its Department of Government Efficiency initiative, has involved substantial workforce reductions across federal health agencies. The administration described the changes as an effort to eliminate duplication and make government more efficient. But the consequences for public health capacity deserve serious examination.
An analysis published by the Partnership for Public Service in September 2026 reported that the CDC workforce was 26.7 percent smaller in February 2026 than it had been in September 2024. The FDA workforce had declined by 21.6 percent. The analysis also reported a 71.9 percent reduction in CDC project grant funding issued in fiscal year 2025 compared with the previous fiscal year. These reductions matter because federal public health agencies do considerably more than conduct research. They provide expertise, funding, surveillance assistance and emergency coordination to state and local health departments across the country.
This is where the consequences become particularly significant. A federal agency can retain its name, its buildings and its official responsibilities while losing much of the experienced personnel necessary to carry them out. Epidemiologists, laboratory specialists, researchers and public health administrators represent years of accumulated knowledge. Replacing that expertise in the middle of an emergency is not something that can be accomplished by simply reorganizing an agency chart.
The Government Accountability Office added another warning in February 2026. Its examination of federal public health preparedness found that the CDC and the Administration for Strategic Preparedness and Response lacked a formal mechanism for coordinating two major preparedness programs serving public health departments and hospitals. The GAO also found that HHS was not adequately collecting and analyzing information about the preparedness capabilities of state and local jurisdictions. These are precisely the kinds of coordination problems that became painfully apparent during COVID-19.
Meanwhile, the threat itself has not disappeared. H5N1 Bird Flu continues circulating among wild birds, poultry and other animals, including dairy cattle in the United States. Human infections have occurred, particularly among people with occupational exposure. As of November 2026, the CDC continues to characterize the risk to the general public as low, and sustained human-to-human transmission has not been identified. That is reassuring, but it is not a reason to abandon surveillance. It is exactly the kind of situation that requires continued monitoring, research and preparation.
There is an important distinction to be made here. America’s scientific capabilities have not disappeared. Its universities, hospitals, laboratories and medical researchers remain among the most sophisticated in the world. The question is whether the institutions responsible for coordinating those resources, identifying emerging threats and responding to emergencies have been maintained at the level necessary to protect the population.
Preparedness requires more than scientific knowledge. It requires adequate funding, experienced leadership, trained personnel, reliable public information and the willingness to act on scientific evidence, even when the findings are politically inconvenient. It also requires international cooperation, because a virus does not recognize political boundaries, administrative reorganizations or budgetary priorities. It simply spreads.
Dr. Nathan Wolfe’s discussion in 2012 was ultimately about anticipating the next threat rather than waiting for it to arrive. Fourteen years later, we have experienced precisely the kind of worldwide emergency he was concerned about. We have developed better scientific tools, learned important lessons and demonstrated what international research cooperation can accomplish. But we have also seen how quickly institutional weaknesses, political divisions and inadequate preparation can turn an outbreak into a catastrophe.
The question posed in that 2012 KCBS broadcast was whether we were prepared for the next big virus. In 2026, following COVID-19 and amid continuing changes to America’s public health institutions, the question has become considerably more urgent.
In 2012, the question was whether we could prepare for the next pandemic. In 2026, the question is whether we have learned enough from the last one to avoid making the same mistakes again.
Here is that episode of KCBS In Depth – Viral Pandemics – April 28, 2012

Share this:
- Share on Facebook (Opens in new window) Facebook
- Share on LinkedIn (Opens in new window) LinkedIn
- Share on Tumblr (Opens in new window) Tumblr
- Share on Mastodon (Opens in new window) Mastodon
- Share on Threads (Opens in new window) Threads
- Share on Bluesky (Opens in new window) Bluesky
- Share on X (Opens in new window) X
- More